Review Goal
The review asked a narrow question:
Does the spoken audio stay faithful to the source papers, especially where clinical interpretation could be overstated?
A monthly special on focal cortical dysplasia: what an integrated diagnosis explains, what anatomy and electrophysiology add, and where AI detection and targeted treatment remain uncertain.
Evidence Standard
The episode was reviewed against the full text of the source articles — not abstracts or summaries — to catch places where the audio could misrepresent scope, effect size, or clinical implications.
- Najm et al. 2022. *The ILAE consensus classification of focal cortical dysplasia: An update proposed by an ad hoc task force of the ILAE diagnostic methods commission.* PMID 35706131: https://pubmed.ncbi.nlm.nih.gov/35706131/; DOI 10.1111/epi.17301
- Wagstyl et al. 2022 (online 2021). *Atlas of lesion locations and postsurgical seizure freedom in focal cortical dysplasia: A MELD study.* PMID 34845719: https://pubmed.ncbi.nlm.nih.gov/34845719/; DOI 10.1111/epi.17130
- Macdonald-Laurs et al. 2023 (online 2022). *Intrinsic and secondary epileptogenicity in focal cortical dysplasia type II.* PMID 36527426: https://pubmed.ncbi.nlm.nih.gov/36527426/; DOI 10.1111/epi.17495
- Ripart et al. 2025. *Detection of Epileptogenic Focal Cortical Dysplasia Using Graph Neural Networks: A MELD Study.* PMID 39992650: https://pubmed.ncbi.nlm.nih.gov/39992650/; DOI 10.1001/jamaneurol.2024.5406
- Kaas et al. 2026. *Independent evaluation of deep learning models for detecting focal cortical dysplasia.* Epilepsy Research 223:107778. Publisher: https://www.sciencedirect.com/science/article/pii/S0920121126000483; DOI 10.1016/j.eplepsyres.2026.107778: https://doi.org/10.1016/j.eplepsyres.2026.107778
- Lim et al. 2015. *Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy.* PMID 25799227: https://pubmed.ncbi.nlm.nih.gov/25799227/; DOI 10.1038/nm.3824
- Kim et al. 2025 (online 2024). *Efficacy and safety of everolimus for patients with focal cortical dysplasia type 2.* PMID 39607729: https://pubmed.ncbi.nlm.nih.gov/39607729/; DOI 10.1002/epi4.13104
Process
The episode was generated directly from the source papers, with explicit instructions to preserve study scope and avoid overstating findings.
The audio was converted to text so spoken claims could be checked line by line against the papers.
Two independent AI-assisted reviews checked spoken claims against the source text and flagged material overstatement, misrepresentation, or unsupported interpretation.
Each complete draft received two independent reviews and one combined editorial verdict: cleared, cleared with minor notes, needs revision, or re-record required. A draft could not advance until accuracy issues were resolved.
Verdict History
| Draft | Verdict | What changed |
|---|---|---|
| Drafts 1–4 | Revision required | Each draft received two independent source reviews and was superseded. |
| Draft 5, edited assembly | Cleared with minor notes | Both independent reviews found no blocking findings after the editorial trims and complete transcription. |
How the Language Changed
These are the specific spoken claims that failed review, shown alongside the corrected language in the published draft. Quoted or closely paraphrased from the transcripts.
Final contextual clarifications
The final episode preserves the distinction between a diagnostic framework, observational clinical evidence, detection performance and controlled treatment evidence.
Final Result
Verdict: Cleared for human listening with minor notes
Two independent full-text reviews cleared the exact final audio for human listening. AI review does not substitute for clinician editorial responsibility.
Minor caveats carried into the show notes
- MTOR variants were not detected in the available blood or saliva samples in Lim’s study; negative peripheral testing does not exclude brain-restricted mosaicism.
- Regional surgical-outcome differences are observational and may reflect surgical constraints; they are not individual predictions.
- No washout in the everolimus crossover trial allows potential carryover and limits interpretation. The trial did not demonstrate overall superiority.
- Independent AI testing evaluates performance under different conditions; detection is not a resection map.
What Changed
- Five candidate rounds; drafts 1–4 superseded.
- Three editorial trims were completed before the final transcript and both independent reviews.
- The final assembly includes the standard AED music introduction.
Production Learning
Full-text review and human listening serve different purposes; clear uncertainty remains part of the final editorial work.
Boundaries
This review does not certify clinical recommendations, replace human editorial judgment, replace independent expert review, transfer responsibility to the authors of the source studies, or make the episode a clinical guideline.